The live webcast may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.
About
Investors:
abraun@acumenpharm.com
Media:
AcumenPR@westwicke.com
Source:
2024 GlobeNewswire, Inc., source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.205 USD | -0.47% | +1.89% | -15.62% |
Apr. 04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
Apr. 04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
The live webcast may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.
About
Investors:
abraun@acumenpharm.com
Media:
AcumenPR@westwicke.com
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-15.62% | 193M | |
-0.38% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.10% | 24.63B | |
-23.92% | 18.2B | |
+26.69% | 12.01B | |
-4.06% | 11.76B | |
+13.89% | 10.4B | |
-4.67% | 9.94B |